Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CELC | CELCUITY INC | Healthcare | 1,704,318.0 | $178.3M | 6.14% | +420K | +32.7% | $104.62 | -9.1% |
| 2 | PODD | INSULET CORP | Healthcare | 1,049,000.0 | $159.7M | 5.50% | +486K | +86.5% | $152.25 | -5.8% |
| 3 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 225,587.0 | $122.2M | 4.21% | +38K | +20.5% | $541.83 | -4.6% |
| 4 | INSP | INSPIRE MED SYS INC | Healthcare | 1,931,436.0 | $86.2M | 2.97% | +1.4M | +235.1% | $44.61 | +38.5% |
| 5 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 1,843,504.0 | $72.1M | 2.48% | +1.8M | +10000.0% | $39.12 | +18.8% |
| 6 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 867,760.0 | $71.8M | 2.48% | +48K | +5.8% | $82.78 | -9.9% |
| 7 | BBNX | BETA BIONICS INC | Healthcare | 4,393,714.0 | $68.8M | 2.37% | +39K | +0.9% | $15.67 | +23.4% |
| 8 | GERN | GERON CORP | Healthcare | 42,808,659.0 | $54.8M | 1.89% | +1.3M | +3.1% | $1.28 | +19.5% |
| 9 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 1,168,738.0 | $36.0M | 1.24% | +717K | +158.6% | $30.83 | -0.2% |
| 10 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 1,465,163.0 | $35.5M | 1.23% | +527K | +56.2% | $24.26 | +10.1% |
| 11 | JBIO | JADE BIOSCIENCES INC | Healthcare | 1,550,690.0 | $34.5M | 1.19% | +754K | +94.6% | $22.22 | -4.0% |
| 12 | — | AVALO THERAPEUTICS INC | — | 1,654,978.0 | $30.6M | 1.05% | +1.2M | +274.4% | $18.48 | — |
| 13 | URGN | UROGEN PHARMA LTD | Healthcare | 829,810.0 | $30.5M | 1.05% | +103K | +14.1% | $36.80 | +24.8% |
| 14 | MBX | MBX BIOSCIENCES INC | Healthcare | 515,279.0 | $28.4M | 0.98% | +336K | +188.0% | $55.20 | +20.9% |
| 15 | PHVS | PHARVARIS N V | Healthcare | 730,907.0 | $25.3M | 0.87% | +29K | +4.1% | $34.58 | +7.0% |
| 16 | ORGO | ORGANOGENESIS HLDGS INC | Healthcare | 10,140,951.0 | $24.6M | 0.85% | +55K | +0.6% | $2.43 | -28.0% |
| 17 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 1,003,000.0 | $22.6M | 0.78% | +843K | +526.9% | $22.58 | -6.7% |
| 18 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 709,000.0 | $22.2M | 0.76% | +259K | +57.6% | $31.26 | -18.5% |
| 19 | ARGX | ARGENX SE | Healthcare | 19,955.0 | $18.5M | 0.64% | +16K | +470.1% | $927.77 | +12.9% |
| 20 | KIDS | ORTHOPEDIATRICS CORP | Healthcare | 732,144.0 | $14.0M | 0.48% | +117K | +19.0% | $19.13 | +25.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%